NYSE: G

Genpact (G) Stock Analysis & Forecast

Nov 13 close

$43.61+0.48 (+1.1%)

Gekko Brief

AI summaryNov 9 close

Genpact's third-quarter results drove this week's move, with revenue rising 7.3% as demand for technology and artificial intelligence services accelerated. The company reported diluted earnings per share of $0.89, up from $0.83 a year earlier, on revenue of $1,385.4 million, with Advanced Technology Solutions net revenue growth of 30% year-over-year. Genpact raised its 2026 guidance for gross margin and adjusted diluted earnings per share, while nine-month operating cash flow decreased to $142.021 million from $526.161 million in 2025, attributed to higher receivables balances.

Shares closed at $42.55, up 0.7%, sitting above both the 50-day average of $36.62 and the 200-day average of $35.39, with the 50-day above the 200-day. The GekkoIndex reads 45.3, placing the stock in the Neutral zone, down 5.3 over five sessions. Price remains 31.5% below Gekko Fair Value of $62.16. One-month and three-month returns stand at 23.7% and 25.3%, with a 52-week range of $26.85 to $48.64.

The next earnings date falls on 4 February 2027, 86 days out and beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality from this point in the calendar has averaged a 2.6% gain over the next 20 trading days across 5 years, rising in 3 of them. Analyst consensus across 8 firms includes 3 buy and 5 hold ratings, with a consensus target of $42.91.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Genpact price vs fair value

▲$61.92$43.61Nov ’25May ’26Nov ’26
Close $43.61200-day averageGekko Fair Value $61.92

Genpact quick facts

Market cap
$7.39B
P/E ratio
12.6
Forward P/E
18.3
EPS, TTM
$3.43
Revenue, TTM
$5.34B
Profit margin
11%
Dividend yield
1.68%
Beta
0.54
Volume
2.44M avg 2.09M
1-year return
−4.2%
Typical daily move
±3.2%
Typical 20-day move
±5.3%
50-day average
$37.06
200-day average
$35.36
Next earnings
Feb 4 after close
Shares outstanding
167.2M
52-week range
$26.85$48.64

Genpact swing-trade checklist

Genpact scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive1 mixed0 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $43.61 is above the 50-day ($37.06) and 200-day ($35.36) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    46, Neutral

    Reading 46 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    29.6% below

    Price is 29.6% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 81 days

    Next report Feb 4, 2027, 81 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +1.3% on average

    From this point in the calendar, the next 20 trading days averaged +1.3% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Genpact stock chart and price history

Genpact closed at $43.61 on Nov 13, 2026, −4.2% over the past year, inside a 52-week range of $26.85 to $48.64.

Close50-day average200-day averageVolume
Genpact share price, past year, with 50-day and 200-day moving averages and volume$30$35$40DecJan 2026FebMarAprMayJunJulAugSepOctNov43.61

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+16.0%
3 months
+29.4%
6 months
+50.1%
1 year
−4.2%
The full G chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open G in Gekko

Follow Genpact through every session

Put G on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track G in GekkoFree for 7 days. No credit card required.

About Genpact

Genpact works with businesses around the globe, handling back-office and technology tasks so clients can hand off process-heavy work. Customers are found across India, other Asian markets, the Americas, and Europe. The firm has built a strong reputation for managing finance and accounting tasks on behalf of other companies, taking on everything from paying invoices to collecting payments to closing the books each period, while also advising finance chiefs and guiding clients through environmental and social reporting requirements.

Client work is grouped into three areas: one centered on banks, capital markets firms, and insurers; another covering consumer goods, retail, life sciences, and healthcare companies; and a third focused on technology, manufacturing, and services businesses. Genpact also handles procurement and sourcing tasks, supply chain coordination, and after-sales assistance, plus sales support like managing orders, resolving disputes, and setting prices. On the technology side, it manages infrastructure, applications, and databases for clients, and it helps organizations shift how they operate through consulting, digital projects, and data analysis.

The company traces back to 1997 and runs its headquarters out of Hamilton, Bermuda. Investors can find its stock listed on the NYSE under the ticker G.

Listed
NYSE
Sector
Commercial services
Industry
Miscellaneous commercial services
Website
genpact.com

Genpact GekkoIndex: the smart money zone

Genpact’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 46, in the Neutral zone, down 0.3 points over five sessions.

010046Neutral

Down 0.3 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying46+1.3%+2.1%+3.3%+5.2%
Accumulation279+0.2%+0.6%+1.5%+2.4%
Neutral (current zone)322+0.1%−0.1%−0.2%+0.1%
Distribution48+0.7%+1.6%+0.1%−0.8%
Selling7Too few readings yet

Average G share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the G price, zone by zone.Track G in Gekko

Is Genpact stock overvalued? Gekko Fair Value

Genpact trades 29.6% below Gekko Fair Value of $61.92, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Genpact shares are worth, recalculated every trading day.

$61.92

Gekko Fair Value, Nov 14, 2026

29.6% Undervalued

At the end of Aug 2026 the price was 42.8% below the estimate.

Gekko Fair ValueShare price, month end
$62$44Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open G in Gekko

Genpact insider and Congress trading

No open-market insider purchases were filed for Genpact, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for G in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every G insider filing, plotted on the chart in Gekko.Open G in Gekko

Congress trades last 90 days

No trades in G were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for G, plotted on the chart in Gekko.Open G in Gekko

Buybacks

Genpact has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$30.96M
As a share of market cap
0.42%
Trailing four quarters
$251.0M

From company filings.

Genpact earnings: next date and track record

Genpact reports on Feb 4, 2027, after the close (81 days away), and beat the EPS estimate in 8 of its last 8 reports.

8 of 8reports beat the EPS estimate
±8.7%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

+13.5%Nov ’24+11.2%Feb ’25−15.4%May ’25+3.2%Aug ’25+14.6%Nov ’25+5.3%Feb ’26−3.7%May ’26−2.8%Aug ’26

Last earnings call, Aug 6, 2026 AI summary

What they said
Genpact reported Q2 2026 revenue of $1.343 billion, up 7.1% year-over-year. Advanced Technology Solutions grew 24.1% YoY, gross margins expanded again, and adjusted diluted EPS rose 13.6% YoY. Non-FTE revenue surpassed 50% of total revenue for the first time. Management is strategically pivoting toward 'Agentic Operations,' repositioning the company as an AI-enabled enterprise workflow leader with expanding TAM.
Guidance
Management raised conviction on long-term growth, originally targeting 7% revenue growth with Advanced Technology Solutions growing mid-teens. They are now accelerating capital allocation toward Agentic Operations and Advanced Technology Solutions, suggesting faster-than-expected strategic pivot and growth trajectory.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 6, 2026$1.00
est $0.97
+3.6%$1.34B
est $1.33B
+0.8%−2.8%
May 7, 2026$0.98
est $0.92
+6.5%$1.30B
est $1.29B
+0.5%−3.7%
Feb 5, 2026$0.97
est $0.94
+3.2%$1.32B
est $1.31B
+0.8%+5.3%
Nov 6, 2025$0.97
est $0.90
+8.0%$1.29B
est $1.27B
+2.0%+14.6%
Aug 7, 2025$0.88
est $0.85
+3.5%$1.25B
est $1.26B
−0.1%+3.2%
May 7, 2025$0.84
est $0.80
+5.0%$1.21B
est $1.21B
+0.5%−15.4%
Feb 6, 2025$0.91
est $0.86
+5.8%$1.25B
est $1.23B
+1.7%+11.2%
Nov 7, 2024$0.85
est $0.80
+6.2%$1.21B
est $1.19B
+2.1%+13.5%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Genpact stock forecast and analyst price targets

Analysts’ average 12-month price target for Genpact is $47.64, +9.2% from the last close, from 8 firms rating the stock in the last 90 days.

$47.64consensus 12-month target, +9.2% from the last close
Low $42High $58
Buy3
Hold5
Sell0

Each firm’s latest rating in the last 90 days: 8 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 11Mizuho SecuritiesHold, maintained$44+0.9%
Nov 9CitiHold, maintained$44+0.9%
Nov 6Robert W. BairdHold, maintained$48+10.1%
Nov 6Bank of America SecuritiesBuy, reiterated$58+33.0%
Nov 6TD CowenBuy, maintained$50+14.7%
−0.2%average 20-day move after past Neutral readings
+1.3%average move over the next 20 trading days in the last 5 years
±3.2%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Genpact seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Genpact averaged +1.3% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−1.8%2021+1.4%2022+3.8%2023−1.0%2024+5.5%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−1.7%1 of 5
Next 10 trading days−1.0%3 of 5
Next 15 trading days+0.9%3 of 5
Next 20 trading days+1.3%3 of 5
Next 30 trading days+1.8%4 of 5

For scale, G’s typical 20-trading-day move in either direction is about 5.3%.

Genpact market cap and key statistics

Genpact’s market cap is $7.39B, with a P/E ratio of 12.6 and revenue of $5.34B over the last twelve months.

Valuation

Market cap
$7.39B
P/E ratio
12.6
Forward P/E
18.3
EPS, TTM
$3.43
Gekko Fair Value
$61.92

Trading

Volume
2.44M
Avg volume, 20 days
2.09M
52-week high
$48.64
52-week low
$26.85
Shares outstanding
167.2M

Financials

Revenue, TTM
$5.34B
Profit margin
11%
Return on equity
22.4%
Quarterly earnings growth, YoY
+7.2%

Risk and income

Beta
0.54
Typical daily move
±3.2%
Typical 20-day move
±5.3%
Dividend yield
1.68%

Genpact peers

Genpact’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
SHOPShopify−0.1%Accumulation0.6% above
CTASCintas−0.6%Neutral22.3% above
PYPLPayPal+1.1%Neutral5.3% above
XYZBlock+2.8%Neutral15.1% above
FISVFiserv+3.7%Distribution38.0% below
CPAYCorpay+0.6%Distribution5.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Miscellaneous commercial services

Genpact stock FAQ

What is Genpact’s market cap?

Genpact’s market cap is $7.39B at the Nov 13, 2026 close of $43.61, with 167.2M shares outstanding. The shares trade on a P/E ratio of 12.6.

What is the Genpact stock forecast?

The consensus analyst 12-month price target for Genpact is $47.64, +9.2% from the last close. Of the 8 firms that rated the stock in the last 90 days, 3 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Genpact stock overvalued or undervalued?

On Gekko’s estimate Genpact is undervalued: the Nov 13, 2026 close of $43.61 is 29.6% below Gekko Fair Value of $61.92. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Genpact report earnings next?

Genpact is expected to report on Feb 4, 2027, after the market closes (81 days away). Analysts expect earnings of $1.09 per share on revenue of $1.41B. Genpact beat the earnings estimate in 8 of its last 8 reports, moving 8.7% on average across the report.

What is Genpact’s 52-week high and low?

Genpact’s 52-week high is $48.64 and its 52-week low is $26.85; it closed at $43.61 on Nov 13, 2026, −4.2% over the past year. Over the last five years the shares peaked at $56.76 on Feb 7, 2025.

Is Genpact stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (trend, fair value, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Genpact the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.